Immediate Impact
1 by Nobel laureates 58 standout
Citing Papers
Osteoarthritis
2025 Standout
Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
2025 Standout
Works of Jens Geiseler being referenced
MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jens Geiseler | 1030 | 324 | 83 | 232 | 42 | 1.3k | |
| Mark R. Elstad | 564 | 384 | 94 | 256 | 29 | 1.4k | |
| Antonio Corrado | 1358 | 346 | 67 | 332 | 52 | 1.6k | |
| Emilio Servera | 886 | 156 | 454 | 179 | 66 | 1.5k | |
| Ben Creagh‐Brown | 503 | 178 | 37 | 93 | 50 | 1.1k | |
| Stephan Budweiser | 1027 | 149 | 43 | 600 | 66 | 1.4k | |
| Michelle Chatwin | 1213 | 241 | 159 | 260 | 36 | 1.6k | |
| Patrick B. Murphy | 1027 | 224 | 76 | 449 | 105 | 1.5k | |
| Jennifer Beck | 1076 | 462 | 11 | 49 | 45 | 1.3k | |
| C Laroche | 842 | 51 | 108 | 159 | 45 | 1.3k | |
| Karen Wolf | 391 | 416 | 117 | 169 | 32 | 1.1k |
All Works
Loading papers...